How Analysts Feel About SeaSpine Holdings Corporation (SPNE) After Touching 52-Week High?

June 16, 2018 - By Hazel Jackson

SeaSpine Holdings Corporation (NASDAQ:SPNE) Logo

The stock of SeaSpine Holdings Corporation (NASDAQ:SPNE) hit a new 52-week high and has $15.03 target or 7.00 % above today’s $14.05 share price. The 8 months bullish chart indicates low risk for the $204.24 million company. The 1-year high was reported on Jun, 16 by If the $15.03 price target is reached, the company will be worth $14.30 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock increased 0.14% or $0.02 during the last trading session, reaching $14.05. About 51,693 shares traded or 10.23% up from the average. SeaSpine Holdings Corporation (NASDAQ:SPNE) has risen 11.03% since June 16, 2017 and is uptrending. It has underperformed by 1.54% the S&P500.

Analysts await SeaSpine Holdings Corporation (NASDAQ:SPNE) to report earnings on August, 2. They expect $-0.49 earnings per share, up 27.94 % or $0.19 from last year’s $-0.68 per share. After $-0.50 actual earnings per share reported by SeaSpine Holdings Corporation for the previous quarter, Wall Street now forecasts -2.00 % EPS growth.

SeaSpine Holdings Corporation (NASDAQ:SPNE) Ratings Coverage

Among 2 analysts covering SeaSpine Holdings (NASDAQ:SPNE), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. SeaSpine Holdings had 3 analyst reports since March 2, 2018 according to SRatingsIntel. The firm has “Buy” rating by H.C. Wainwright given on Friday, March 2. The firm has “Buy” rating by H.C. Wainwright given on Friday, May 4.

More news for SeaSpine Holdings Corporation (NASDAQ:SPNE) were recently published by:, which released: “Premarket analyst action – healthcare” on June 01, 2018.‘s article titled: “As Spinal Stocks Climb Toward Yearly Highs, There’s Still Room for Upside” and published on June 07, 2018 is yet another important article.

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and Internationally. The company has market cap of $204.24 million. The firm provides orthobiologics and spinal fusion hardware solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. It currently has negative earnings. The Company’s orthobiologics products include demineralized bone matrices, collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to enhance bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.